Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
0.010 Biomarker disease BEFREE In the HELIOS trial, bendamustine/rituximab (BR) plus ibrutinib (BR-I) improved disease outcomes versus BR plus placebo in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma. 31044267 2019